PTC THERAPEUTICS INC - NOTE 1.500% 9/1

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Debt / NOTE 1.500% 9/1
Market price (% of par)
148.24%
Total 13F principal
$232,857,000
Principal change
+$3,014,000
Total reported market value
$346,049,605
Number of holders
14
Value change
+$11,387,320
Number of buys
6
Number of sells
8

Institutional Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of Q4 2025

As of 31 Dec 2025, PTC THERAPEUTICS INC - NOTE 1.500% 9/1 was held by 14 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $232,857,000 in principal (par value) of the bond. The largest 10 bondholders included FRANKLIN RESOURCES INC, TENOR CAPITAL MANAGEMENT Co., L.P., CAPSTONE INVESTMENT ADVISORS, LLC, Sculptor Capital LP, Linden Advisors LP, DeepCurrents Investment Group LLC, WHITEBOX ADVISORS LLC, CSS LLC/IL, SSI INVESTMENT MANAGEMENT LLC, and BlackRock, Inc.. This page lists 14 institutional bondholders reporting positions for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.